Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionVirtus ETF Advisers LLC
Latest Disclosed Ownership2,584 shares
Latest Disclosed Value $ 340,416
Virtus ETF Advisers LLC ownership in NBIX / Neurocrine Biosciences, Inc.

On May 14, 2026 - Virtus ETF Advisers LLC filed a 13F-HR form disclosing ownership of 2,584 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $340,416 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,584 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,584 0 0.00 340 -7.10 0.0965
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,584 0 0.00 366 1.10 0.1733
2026-02-13 2025-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 2,584 0 0.00 363 11.73 0.1998
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,584 0 363 0.2378
2026-02-13 2025-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 2,584 0 0.00 325 13.68 0.1982
2025-08-13 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 650 -1,934 82 0.1079
2026-02-13 2025-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 2,584 -174 -6.31 286 -24.20 0.1855
2025-05-14 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,584 -174 286 0.3715
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,758 341 14.11 376 35.25 0.1537
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,417 0 0.00 278 -16.27 0.1302
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,417 -723 -23.03 333 -23.33 0.1630
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,140 452 16.82 433 22.32 0.2301
2024-02-15 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,688 -539 -16.70 354 -2.48 0.2248
2023-11-07 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,227 -420 -11.52 363 5.83 0.2205
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,647 1,062 41.08 344 31.42 0.2038
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,585 48 1.89 262 -13.86 0.1439
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,537 -45 -1.74 303 10.58 0.1582
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,582 38 1.49 274 10.48 0.1093
2022-08-12 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,544 -1,953 -43.43 248 -41.23 0.0919
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,497 0 0.00 422 10.18 0.1889
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,497 -97 -2.11 383 -13.15 0.1446
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,594 -418 -8.34 441 -9.63 0.1940
2021-08-10 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,012 -1,680 -25.10 488 -25.04 0.2007
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,692 180 2.76 651 4.33 0.2750
2021-02-12 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,512 1,421 27.91 624 27.35 0.2590
2020-11-13 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,091 284 5.91 490 -16.52 0.2570
2020-08-05 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,807 -515 -9.68 587 27.33 0.2780
2020-05-14 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,322 -449 -7.78 461 -25.65 0.1897
2020-02-13 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,771 -2,479 -30.05 620 -16.55 0.1014
2019-11-12 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,250 -1,396 -14.47 743 -8.72 0.1497
2019-08-13 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,646 -1,025 -9.61 814 -13.40 0.1716
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,671 2,386 28.80 940 58.78 2.0000
2019-02-05 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,285 462 5.91 592 -38.46 0.1012
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,823 527 7.22 962 34.17 0.0994
2018-08-10 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,296 -5,603 -43.44 717 -32.99 0.6339
2018-05-14 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,899 -753 -5.52 1,070 1.04 0.9284
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,652 -9,899 -42.03 1,059 -26.61 1.3289
2017-11-14 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 23,551 0 0.00 1,443 33.24 0.1945
2017-08-14 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 23,551 17,076 263.72 1,083 286.79 0.1616
2017-05-15 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,475 621 10.61 280 23.35 0.0499
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,854 530 9.95 227 -15.93 0.0678
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,324 0 0.00 270 11.57 0.1305
2016-08-15 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,324 564 11.85 242 28.72 0.1796
2016-05-16 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,760 4,760 188 0.2590
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.